Weight loss drugs boom drives pharma R&D returns, but industry could face ‘bubble’ effect
Top global pharma companies’ return on R&D increased for third consecutive year; Growth is almost entirely driven by GLP-1 drugs - used to treat obesity and diabetes - and accounts for 38% of projected sales;Obesity drugs have displaced oncology dr
Sable&Hawkes deliver new multi-million environment development project for Luton and Dunstable NHS
Client: Bedfordshire Hospitals NHS Foundation Trust Project: New Acute Services & Multi-Ward Block
Innovate Cambridge to recognise a new wave of companies at the Business Weekly Awards
Innovate Cambridge has announced a new award category for this year’s prestigious Business Weekly Awards, recognising a new generation of science and technology companies redefining what successful innovation looks like.
Daniel Zeichner MP welcomes Astrazeneca’s £300 million investment as boost for Cambridge
Daniel Zeichner, MP for Cambridge, has welcomed the announcement made by the Prime Minister, Sir Keir Starmer, during Prime Minister’s Questions today that AstraZeneca will invest £300 million into the UK’s life sciences sector.
Lab Thread introduces Unified Lab Software Platform to streamline biological research
Connects scientific teams, data and workflows within a single, fully integrated digital lab management system
CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plus™ into Gynecology
Following Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds On Extensive Global Clinical Experience in Gynecology and Continues CMR’s U.S. Market Expansion
EpilepsyGTx appoints Professor Dimitri Kullmann as Chief Scientific Officer
Appointment of UCL Neurologist will accelerate the delivery of novel gene therapies for refractory epilepsy
It’s time to govern your team’s AI use
Do you know which AI tools your team is using at work… and what they’re putting into them?
Most senior leaders we speak to think they do. Until we dig a little deeper.
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers
New PTC Harmony Thermal Cycler Line Expands Access to Reliable, High-Performance PCR Across Academic and Biopharma Laboratories
From licensing to integration: is decision-making in life sciences moving upstream?
Recent cross-border licensing activity involving China-origin biopharmaceutical assets suggests a subtle but important shift in how global partnerships are being structured. While attention often focuses on total deal value, the more meaningful signal may lie in the underlying terms.
PlaqueTec closes $5 million financing
Oversubscribed round backed by existing shareholders Investment will support development of cardiovascular disease database to be used to inform patient stratification and therapeutic development programmesCambridge, UK, 27 April 2026:
AstraZeneca and Northern Ireland Forge New Strategic Partnership Aiming to Transform Healthcare and Boost Innovation
Belfast, UK, April 24, 2026 – AstraZeneca and Northern Ireland Department of Health, the Department for the Economy and the Health Innovation Research Alliance NI (HIRANI) today announced their intent to enter into a first-of-its-kind strategic Memorandum of Understanding (MOU), aimed at transforming healthcare delivery and improving health outcomes for the people of Northern Ireland.
Build your next big, bold and beautiful controlled environment facility with Cleanroom Solutions
Guardtech’s turnkey brand are redefining high-spec cleanroom construction by marrying operational excellence and environmental efficiency with new installation innovation and stunning aesthetics
Building buyer personas that genuinely resonate with scientist buyers
Learn how stronger buyer personas can sharpen Life Sciences marketing strategy and access a free, ready-to-use template.
When both sides have rules: What this means for UK–China life sciences collaboration
For UK life sciences businesses engaging with China, the operating environment has become more structured than many still assume. Not because the opportunity has diminished — it has not — but because the conditions for realising it now require a different level of preparation.
East Anglian Air Ambulance launches £8.2m appeal to build new Cambridge base
Former patients help charity launch appeal as it calls on people and businesses across Cambridgeshire to help protect the future of their local air ambulance.
Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies
BioResource scientific conference returns for 2026
Join us for the fourth edition of the NIHR BioResource Scientific Conference on Wednesday 17th June.
STORM Therapeutics secures $56 million series C financing and doses first patient in phase 2 Sarcoma Trial of STC‑15
The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms malignant progenitor cells by modulating mRNA methylation16 April 2026, Cambridge, UK: STORM Therapeutics Ltd.
Bridging Cambridge’s MedTech scale-up gap: the missing link between prototype and production
Cambridge leads in early-stage MedTech innovation, but many promising ideas stall when moving from lab prototypes to clinical-ready devices. The core challenge lies in fragmented, early-stage manufacturing and regulatory pathways, often pushing companies to look overseas. This reflects a broader UK gap in scaling MedTech innovation.
The retinal delivery bottleneck: why today’s tools won’t scale
Cell and gene therapies make up a large and growing proportion of pipeline treatments for high-prevalence diseases of the retina. For these advanced therapies to deliver on their promise, most need to be delivered into the retina, overcoming significant physiological barriers. But existing retinal delivery is a slow, skilled, small-scale business: enabling patients with high-prevalence diseases…
'Addenbrooke's saved my twin sister - and her baby': the powerful stories inspiring Addenbrooke’s Charitable Trust’s TCS London Marathon runners
Addenbrooke's Charitable Trust (ACT) has a record 18 runners in this year's TCS London Marathon. Not only that - but to date they have also raised a record £54,000 between them. To hear their stories, and to find out why they are running to raise funds for Addenbrooke's and the Rosie, see below.
Supporting busy teams with practical 90-minute Microsoft Copilot training
Help your team save time, reduce manual work, and get more from Microsoft Copilot. These 90-minute, instructor-led sessions focus on practical skills your team can start using immediately in Excel, Word and PowerPoint.